AG
TPTX

Advisor Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Advisor Group’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Buy
+18
New +$856 ﹤0.01% 5247

Other funds holding TPTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Advisor Group's TPTX Position: Q4 2019 in Review

Advisor Group opened a new position in Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q4 2019: 18 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #5247 among its holdings.

120 funds tracked by Wall St. Rank hold TPTX as of Q4 2019.

  • Advisor Group held 18 shares of Turning Point Therapeutics, Inc. Common Stock worth $1K as of Q4 2019.
  • Turning Point Therapeutics, Inc. Common Stock was a new Advisor Group position in Q4 2019.
  • Turning Point Therapeutics, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5247 holding.
  • 120 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.